- Home
- CURV vs OLMA Comparison
CURV vs OLMA Comparison
Compare CURV & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURV
- OLMA
- Stock Information
- Founded
- CURV 2001
- OLMA 2006
- Country
- CURV United States
- OLMA United States
- Employees
- CURV N/A
- OLMA N/A
- Industry
- CURV Clothing/Shoe/Accessory Stores
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- CURV Consumer Discretionary
- OLMA Health Care
- Exchange
- CURV Nasdaq
- OLMA Nasdaq
- Market Cap
- CURV 307.0M
- OLMA 299.7M
- IPO Year
- CURV 2021
- OLMA 2020
- Fundamental
- Price
- CURV $3.03
- OLMA $4.65
- Analyst Decision
- CURV Hold
- OLMA Strong Buy
- Analyst Count
- CURV 4
- OLMA 4
- Target Price
- CURV $5.00
- OLMA $24.50
- AVG Volume (30 Days)
- CURV 1.1M
- OLMA 825.6K
- Earning Date
- CURV 09-03-2025
- OLMA 08-05-2025
- Dividend Yield
- CURV N/A
- OLMA N/A
- EPS Growth
- CURV N/A
- OLMA N/A
- EPS
- CURV 0.09
- OLMA N/A
- Revenue
- CURV $1,089,931,000.00
- OLMA N/A
- Revenue This Year
- CURV N/A
- OLMA N/A
- Revenue Next Year
- CURV N/A
- OLMA N/A
- P/E Ratio
- CURV $32.92
- OLMA N/A
- Revenue Growth
- CURV N/A
- OLMA N/A
- 52 Week Low
- CURV $2.18
- OLMA $2.86
- 52 Week High
- CURV $9.14
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- CURV 31.60
- OLMA 52.46
- Support Level
- CURV $2.62
- OLMA $4.38
- Resistance Level
- CURV $2.94
- OLMA $5.01
- Average True Range (ATR)
- CURV 0.22
- OLMA 0.30
- MACD
- CURV -0.03
- OLMA 0.05
- Stochastic Oscillator
- CURV 16.08
- OLMA 63.64
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.